Alta Capital Management Cut Dr Pepper Snapple Grp (DPS) position; The sentiment of Repligen (RGEN) is 1.39



<! –

Trending Stock News

->

August 26, 2018 – By Catherine Smith

Dr Pepper Snapple Group, Inc. (NYSE: DPS) logo

Alta Capital Management Llc reduced Dr Pepper's Snapple Grp (DPS) bet by 74.82% reported in 2018Q1 SEC filing. Alta Capital Management Llc sold 14,029 shares as the share of Dr Pepper Snapple Grp (DPS) increased 3.79%. The Alta Capital Management Llc holds 4,721 shares with a value of $ 558,000, compared with 18,750 in the last quarter. Dr Pepper Snapple Grp now has a value of $ 22.29B. The share rose by 0.60% or $ 0.74 to $ 123.66 during the last trading session. Approximately 5.54M shares traded or 24.93% higher than the average. Dr. Pepper Snapple Group, Inc. (NYSE: DPS) has risen 29.00% since 26 August 2017 and is on the rise. It has performed 9.43% better than the S & P500. Some historical DPS news: 29/03/2018 – LACERA: 3-29-18 DPS 4-4-18 Agenda; 08/03/2018 – JAB HOLDINGS MAKES A PROPOSAL TO BUY DPS IN OCTOBER 2017; 25/04/2018 – Dr. Pepper Snapple: 1Q Adj EPS 88c; 25/04/2018 – FRASERS HOSPITALITY TRUST 2Q DPS 1.1126 SINGAPORE CENTS; 11/05/2018 – Moody & # 39; s Downgrades Dr Pepper Snapple Ratings for Baa2; Provides ratings to finance Keurig Dr Pepper transactions; 03/05/2018 – Dr Pepper Snapple Group and Keep America Beautiful Award more than 900 recycling bins through 34 subsidies to improve recycling in public parks; 15/05/2018 – JANA ADDED ADSK, ANTM, BSX, LRCX, DPS IN 1Q: 13F; 17/05/2018 – Chicago Teamsters start an attack against Dr. Pepper Snapple & # 39; s American bottling machine next week; 16/05/2018 – DEEP ECO: Dr. Pepper Snapple May Benefit, Industry Rises in April; 15/05/2018 – Jana Shops for more consumer brands with Dr Pepper Snapple Stake

Repligen Corp. (RGEN) investor sentiment increased to 1.39 in 2018 Q1. It is 0.13 higher, from 1.26 in 2017Q4. The ratio increased as 82 institutional investors rose and new holdings began, while 59 positions in Repligen Corp. sold and shortened. The institutional investors in our database now hold: 35.98 million shares, an increase compared to 35.19 million shares in 2017Q4. The number of institutional investors holding Repligen Corps in the top ten also rose from 0 to 1 for an increase of 1. Sold All: 13 Reduced: 46 Raised: 63 New Position: 19.

Of the 2 Dr Pepper Snapple Group analysts (NYSE: DPS), I have 1 rating, 0 Sell and 1 Hold. That is why 50% is positive. Dr Pepper Snapple Group had 3 analyst reports since March 14, 2018 according to SRatingsIntel. The company earned the "Hold" score on Tuesday, June 19 by Stifel Nicolaus. Stifel Nicolaus maintained the stock with "Buy" score on Wednesday, March 14 report. The rating was upgraded on Monday, March 19 by RBC Capital Markets to "outperform".

Alta Capital Management Llc increased the interest of Expedia Group (NASDAQ: EXPE) by 18,719 shares to 196,836 to $ 21.73M in 2018Q1. It also increased the share of Markel Corp. (NYSE: MKL) with 600 shares and now owns 19,094 shares. Starbucks (NASDAQ: SBUX) has also been brought up.

Another recent and important news from Dr Pepper Snapple Group, Inc. (NYSE: DPS) was published by Streetinsider.com, which published an article with the title: "Jana & # 39; s 13F shows new interest in Facebook (FB), Dr. Pepper Snapple (DPS), Wells Fargo (WFC), Increase in Pinnacle … "on August 14, 2018.

More notable recent Repligen Corporation (NASDAQ: RGEN) news was published by: Nasdaq.com, which published: "Recent analysis shows STMicroelectronics NV, Jagged Peak Energy, Inovalon, AC Immune SA, Repligen and …" on August 22, 2018, also Benzinga.com with their article: "The Daily Biotech Pulse: Immunomedics" Bottom-Line Miss; Kala, Regeneron Await FDA Verdict "published on August 24, 2018, Globenewswire.com published:" Repligen reports financial results second quarter 2018 "On August 2, 2018. More interesting news about Repligen Corporation (NASDAQ: RGEN) was released by: Benzinga .com and their article:" The Daily Biotech Pulse: Novartis Breast Cancer Trial Meets Endpoint, Medpace's Offering, Dexcom Buys TypeZero "published on August 23, 2018 as well as the news article from Seekingalpha.com entitled:" Repligen Corporation (RGEN) CEO Tony Hunt on the results of Q2 2018 – Earnings Call Transcript "with publication date: August 5, 2018.

The shares rose by 1.44% or $ 0.75 during the last trading session and reached $ 52.95. Approximately 406,917 shares traded or 37.54% more than the average. Repligen Corporation (RGEN) has increased by 11.84% since 26 August 2017 and is on the rise. It did less well with 0.73% of the S & P500. Some historical RGEN news: 08/05/2018 – REPLIES CORP RGEN.O LOOKS UNTIL 2018 REVENUE $ 182 MLN TO $ 188 MLN; 08/05/2018 – Repligen increases FY18 view on Adj EPS 69c-Adj EPS 73c; 02/05/2018 – Wells Capital Management Inc. leave position in Repligen; 17/05/2018 – Replicate to participate in the 15th annual Craig-Hallum institutional investor conference; 08/05/2018 – REPLY FY REV. GUIDELINE INCREASED TO $ 182 – $ 188M, EST. $ 183.6M; 08/05/2018 – Repligen had seen FY18 Rev $ 180M- $ 186; 19/04/2018 – DJ Repligen Corporation, Inst Holders, 1Q 2018 (RGEN); 08/05/2018 – Repligen increases FY18 view to rev $ 182M- $ 188M; 08/05/2018 – Repligen increases FY18 rendering to EPS 32c-EPS 36c; 17/05/2018 – Dir Ryan Jr Gifts 900 Or Repligen Corp

Repligen Corporation, a bioprocess company, focuses on the development, production and commercialization of products used for the production of therapeutics for antibodies, recombinant proteins and vaccines worldwide. The company has a market capitalization of $ 2.32 billion. It makes different forms of Protein A, a critical component used to purify antibody drugs. It has a P / E ratio of 101.63. The company also provides alternating tangential flow system filtration devices and protein cell culture supplements used in the clinical and commercial production phase to improve biological drug yield.

Conestoga Capital Advisors Llc holds 2.22% of its portfolio in Repligen Corporation for 1.60 million shares. Ranger Investment Management L.P. owns 691,422 shares or 1.85% of their US portfolio. In addition, Pier Capital Llc invested 1.32% in the company for 213,134 shares. Minnesota-based Summit Creek Advisors Llc has invested 1.1% in the shares. Palisade Capital Management Llc Nj, a New Jersey fund, has reported 762,044 shares.

Since January 1, 0001 it had 0 insider purchases and 7 sales transactions for an activity of $ 12.73 million.

Analysts are waiting for it Repligen Corporation (NASDAQ: RGEN) to report the profit on 8 November. They expect $ 0.18 earnings per share, an increase of 20.00% or $ 0.03 from the $ 0.15 of last year per share. RGEN's profit is $ 7.89 million for 73.54 P / E when the $ 0.18 EPS becomes a reality. After $ 0.16 actual earnings per share reported by Repligen Corporation for the previous quarter, Wall Street now forecasts 12.50% earnings per share.

Repligen Corporation (NASDAQ: RGEN) Diagram of institutional positions

Receive news and ratings via e-mail – Enter your e-mail address below to receive a concise, daily summary of the latest news and analysts' reviews with our FREE daily e-mail newsletter.


Source link

Leave a Reply